Sabitlenmiş Tweet
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals.
tandfonline.com/doi/full/10.10…
English
Mikel Portu
532 posts
Mikel Portu
@MGrive92
MD, Oncology.
Barcelona, Spain Katılım Haziran 2012
1.2K Takip Edilen285 Takipçiler
El Dr.Flores, R4 d’#OncoSantPau, presenta un pòster al congrès europeu de càncer de mama #ESMOBreast26.
#orgullsantpau @HospitalSantPau @IRSantPau
Català
Mikel Portu retweetledi
El Dr.Portu ha publicat una revisió de carcinomes renals amb reordenament de TFE3 o alteracions TFEB.
Enhorabona! #orgullsantpau @HospitalSantPau @IRSantPau
Mikel Portu@MGrive92
Happy to share our comprehensive review on MiT-RCC — now published in @Cancers_MDPI! 🔗 doi.org/10.3390/cancer… TFE3/TFEB-driven kidney cancers are rare but increasingly treatable. We review the molecular biology, modern diagnostics, and emerging evidence for ICI + VEGFR-TKI combinations in metastatic tRCC. Key takeaway: fusion partner identity shapes both prognosis and treatment response. Precision matters. Thanks to the whole team — @MarioBalsaMD @OncoSantPau @ICO_oncologia @myESMO @_SEOM @OncoAlert @Uromigos @IKCCorg @RenalCancerNews
Català
Happy to share our comprehensive review on MiT-RCC — now published in @Cancers_MDPI!
🔗 doi.org/10.3390/cancer…
TFE3/TFEB-driven kidney cancers are rare but increasingly treatable. We review the molecular biology, modern diagnostics, and emerging evidence for ICI + VEGFR-TKI combinations in metastatic tRCC.
Key takeaway: fusion partner identity shapes both prognosis and treatment response. Precision matters.
Thanks to the whole team — @MarioBalsaMD @OncoSantPau @ICO_oncologia
@myESMO @_SEOM @OncoAlert @Uromigos @IKCCorg @RenalCancerNews
English
Mikel Portu retweetledi
Our new review is out! 📚 @Cancers_MDPI
🔗 mdpi.com/2072-6694/18/6…
🤔 TFE3-rearranged and TFEB-altered renal cell carcinomas remain among the most fascinating (and challenging) entities within MiT family RCCs
In this review we dissect:
🧬 Molecular landscape of MiT-RCC
🎯 Key diagnostic tools (GPNMB IHC, TRIM63 RNA ISH…)
💥 Emerging evidence for ICI + VEGFR-TKI combinations in M1 disease
In MiT-RCC, when TFE3/TFEB rearrange the genome…they also rearrange the way we think about kidney cancer 💡
Thank you to my friend @MGrive92 and to all the team from @OncoSantPau & @ICO_oncologia!
@OncoAlert @OncoReporte @myESMO @_SEOM @Uromigos @IKCCorg @RenalCancerNews
English
Letetresgene autoleucel in advanced non-small cell lung cancer: a step towards truly personalized immunotherapy? tlcr.amegroups.org/article/view/1…
English
Mikel Portu retweetledi
🏆 #EMUC25 Best Abstract Award - M.I. Galante Romo, Madrid (ES)
For the paper: "Real world evidence of adjuvant pembrolizumab in renal cell carcinoma (RCC) from a Spanish registry: The ARENAL trial from the GUARD consortium."
English
Mikel Portu retweetledi
Soon finishing day 2 of our 14th ETOP Residential Workshop with great presentations from the faculty, very interesting project proposals from our participants and lively discussions.
English
First-Line Osimertinib in a Patient Having NSCLC With a Rare Duplication Mutation in the EGFR Exon 19 Region (NM_005228.5:c.2214_2231dup p.(Ile740_Lys745dup)) - Clinical Lung Cancer clinical-lung-cancer.com/article/S1525-…
English
Molecular Determinants of Survival in Metastatic Uveal Melanoma: The I... sciencedirect.com/science/articl…
English
Mikel Portu retweetledi
Magnífica presentació de “First line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study” per @margamajem @OncoSantPau @myESMO #ELCC25
Català
The XRP and ADA “communities” are the loudest and least valuable bot groups on X. Ship something, and then I’ll respond.
I have no animosity towards people that make money. But where are the users.
You can’t gaslight me, idiots, I’ve been around too long and dgaf about mobs.
English
Mikel Portu retweetledi
💜 Cursa anual benèfica per la investigació en Càncer Renal ‼️#els10dlf
🏃♂️🏃🏃♀️ 10km
📅 Diumenge 17 de Novembre
🕙 10h
Inscripcions: xipgroc.cat/ca/curses/LesF…
@HospitalSantPau @IRSantPau @Maroto5Pablo @GeorgiaAnpa @MGrive92
Esports Les Franqueses@esportsLFdV
Aquest cap de setmana se celebren els 10 km de #lesFraqueses i la seva versió mini. Recordeu que són curses solidàries en benefici de la investigació contra el càncer de ronyó de l'Hospital de Sant Pau. Si us hi voleu inscriure, entreu aquí lesfranqueses.cat/actualitat/not…
Català
Mikel Portu retweetledi
THEOREMM: A Novel Framework for Cancer Registration Trials.
"Trials in HEmatology and Oncology REviewed by Metaresearch Methods" drugdevletter.com/p/theoremm-a-n… via @VPrasadMDMPH & @Timothee_MD
English
Mikel Portu retweetledi
Avui hem fet l'acte de comiat dels i les residents de darrer any de l'@ICO_oncologia.
Enhorabona per haver finalitzat l'especialitat i molts èxits en aquesta nova etapa que ara comenceu!
De ben segur esteu preparats! 💪
#ICONICpeople #residents
Català
Great time at #GUARDSymposium2024
MJosé Juan@mjuanfi81
If you are starting in the genitourinary world,if you need to convey your ideas,if you want us to help you dive in,here you have the QR.Sign up and we will contact you.The YOUNG GROUP is already up and running @T_AlonsoGordoa @JaviMolinaC @Uro_Oncologist @elenasefer @Dav_Lorente
English
Mikel Portu retweetledi
Bladder surgery sparing approaches will superceed cystectomy according to @AndreaNecchi . #GUARDSymposium2024
English
@Steven_Hyden So good. In the car outside should have been a huge hit
English
